Clinical symptoms and comorbidity: Significance for the prognostic classification of cancer

Cancer

Volumn 77, Issue 5, 1996, Pages 834-842

  Piccirillo, Jay F ^a   Feinstein, Alvan R ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

comorbidity; multivariate analysis; neoplasm staging; outcome assessment; prognosis; treatment outcome

Indexed keywords

CANCER CLASSIFICATION; CANCER STAGING; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; REVIEW; TREATMENT OUTCOME;

HUMANS; NEOPLASM STAGING; NEOPLASMS; PROGNOSIS;

EID: 0030042238     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960301)77:5<834::AID-CNCR5>3.0.CO;2-E     Document Type: Review

References (50)

1. Cancer Registries Amendment Act of 1992, 42 USC §201.
2. Beahrs OH, Henson DE, Huttler RVP, Kennedy BJ, editors. Manual for staging of cancer. 4th ed. Philadelphia: JB Lippincott, 1992.
3. Denoix PF, Schwartz D. Regeles generales de classification des cancers et de presentation des resultats therapeutics. (Translated from French.) Academie De Chirurgie (Paris) 1959;85:415-24.
4. Hermanek P, Sobin LH, editors. UICC TNM Classification of malignant tumors. 4th ed. 2nd rev. Berlin: Springer-Verlag, 1992.
5. Copeland MM. Clinical staging of cancer for end result reporting. In: Yearbook of Cancer. Chicago: The Yearbook Publishers, 1960:498-503.
6. Burke HB, Henson DE. Criteria for prognostic factors and for an enhanced prognostic system. Cancer 1993;72:3131-5.
7. Feinstein AR. On classifying tumors while treating patients. Arch Intern Med 1985;145:1789-91.
8. Macdonald I. The individual basis of biologic variability in cancer [editorial]. Surg Gynecol Obstet 1958;106:227-9.
9. Barr LC, Baum M. Time to abandon TNM staging of breast cancer? Lancet 1992;339.915-7.
10. Rubin P. A unified classification of cancers: An oncotaxonomy with symbols. Cancer 1973;31:963-82.
11. Feinstein AR. Symptoms as an index of the biological behavior and prognosis in human cancer. Nature 1966;209:241-5.
12. Feinstein AR. A new staging system for cancer and a reappraisal of 'early' treatment and 'cure' by radical surgery. N Engl J Med 1968;279:747-53.
13. Taylor WF, Ivins JC, Unni KK, Beabout JW, Golenzer HJ, Black LE. Prognostic variables in osteosarcoma: a multiinstitutional study. J Natl Cancer Inst 1989;81:21-30.
14. Neel HB, Taylor WF, Pearson GR. Prognostic determinants and a new view of staging for patients with nasopharyngeal carcinoma. Ann Otol Rhinol Laryngol 1985;94:529-37.
15. Peipert JF, Wells CK, Schwartz PE, Feinstein AR. The impact of symptoms and comorbidity on prognosis in stage IB cervical cancer. Am J Obstet Gynecol 1993;169:598-604.
16. Karnofsky DA, Abelman WH, Graver LF, Burchenal JH. The use of nitrogen mustard in the palliative treatment of carcinoma with particular reference to bronchogenic carcinoma, Cancer 1948;1:634-69.
17. Satariano WA. Comorbidity and functional status in older women with breast cancer: implications for screening, treatment, and prognosis. J Gerontol 1992;47 (Special Issue):24-31.
18. Feinstein AR. The pre-therapeutic classification of comorbidity in chronic disease. J Chron Dis 1970;23:455-69.
19. Wells CK, Stoller JK, Feinstein AR, Horwitz RI. Comorbid and clinical determinants of prognosis in endometrial cancer. Arch Intern Med 1984;144:2004-9.
20. Clemens JD, Feinstein AR, Holabird N, Cartwright S. A new clinical-anatomic staging system for evaluating prognosis and treatment of prostate cancer. J Chron Dis 1986;39:913-28.
21. Satariano WA, Ragland DR. The effect of comorbidity on 3-year survival of women with primary breast cancer. Ann Intern Med 1994;120:104-10.
22. Feinstein AR. Clinical Biostatistics XLI. Hard science, soft data, and the challenges of choosing clinical variables in research. Clin Pharmacol Ther 1977;22:485-98.
23. Feinstein AR. Symptomatic patterns, biologic behavior, and prognosis in cancer of the lung. Practical application of Boolean algebra and clinical taxonomy. Ann Intern Med 1964;61:27-43.
24. Feinstein AR, Schimpf CR, Hull EW. A reappraisal of staging and therapy for patients with cancer of the rectum. Arch Intern Med 1975;135:1441-53.
25. Feinstein AR, Schimpff CR, Andrews JF, Wells CK. Cancer of the larynx: A new staging system and a re-appraisal of prognosis and treatment. J Chron Dis 1977;30:277-305.
26. Piccirillo JF, Wells CK, Sasaki CT, Feinstein AR A new clinical-severity staging system for cancer of the larynx. Five-year survival rates. Ann Otol Rhinol Laryngol 1994;103:83-92.
27. Spitzer WO, Dobson AJ, Hall J, Chesterman E, Levi J, Shepard R. Measuring the quality of life of cancer patients. J Chron. Dis 1981;34:585-97.
28. Zubrod CG, Schneiderman M, Frei E, Brindley C. Appraisal of methods for the study of chemotherapy in man: Comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide. J Chron Dis 1960;11:7-33.
29. Mendelsohn J. Principles of neoplasia. In: Wilson JD, Braunwald E, Isselbacher KJ, Petersdorf RG, Martin JB, Fauci AS, et al. editors. Harrison's principles of internal medicine. 12th ed. New York: McGraw-Hill, 1991:1581-4.
30. Chabner BA. Oncology - Introduction. In: Wyngaarden JB, Smith LH, Bennett JC, editors. Cecil textbook of medicine. 19th ed. Philadelphia: W.B. Saunders Co, 1992:1018-22.
31. Zelen M. Keynote Address on Biostatistics and Data Retrieval. Cancer Chemother Reports 1973;4(2):31-42.
32. Stell PM. Prognosis in laryngeal carcinoma: host factors. Clin Otolaryngol 1990;15:111-9.
33. Kaplan MH, Feinstein AR. The importance of classifying initial comorbidity in evaluating the outcome of diabetes mellitus. J Chron Dis 1974;27:387-404.
34. Concato J, Horwitz RI, Feinstein AR, Elmore JG, Schiff SF. Problems of comorbidity in mortality after prostatectomy. JAMA 1992;267:1077-82.
35. Greenfield S, Bianco DM, Elashoff RM, Ganz PA. Patterns of care related to age of breast cancer patients. JAMA 1987;257:2766-70.
36. Bailey BJ. Beyond the 'new' TNM classification [editorial]. Arch Omlaryngol Head Neck Surg 1991;117:369-70.
37. American Joint Committee for Cancer Staging and End Results Reporting. Manual for staging of cancer. Chicago: American Joint Committee, 1977.
38. Feinstein AR, Wells CK. A clinical-severity staging system for patients with lung cancer. Medicine 1990;69:1-33.
39. Edwards WM, Cox RS, Garland LH. The solitary nodule (coin lesion) of the lung: an analysis of 52 consecutive cases treated by thoracotomy and a study of preoperative diagnostic accuracy. Am J Roentgenol 1962;88:1020-42.
40. Vineis P, Sinistrero G, Temporelli A, Azzoni L, Bigo A, Burke P, et al. Inter-observer variability in the interpretation of mammogram. Tumori 1988;74:275-9.
41. Feinstein AR, Kramer MS. Clinical Biostatistics: LII. The architecture of observer/method variability and other types of process research. Clin Pharmacol Ther 1980;28:551-63.
42. Gilchrist KW, Gould VE, Hirschl S, Imbriglia JE, Patchefsky AS, Penner DW, et al. Interobserver variation in the identification of breast carcinoma in intramammary lymphatics. Hum Pathol 1982;13:170-2.
43. Robertson AJ, Anderson JM, Swanson BJ, Burnett RA, Howatson SR, Lee FD, et al. Observer variability in histopathological reporting of cervical biopsy specimens. J Clin Pathol 1989;42:231-8.
44. Feinstein AR. Clinimetrics. New Haven: Yale University Press, 1987.
45. Mahoney FI, Barthel DW. Functional evaluation: The Barthel Index. MD State Med J 1965;14:61-5.
46. Stewart AL, Hays RD, Ware JE. The MOS short-form general health survey: reliability and validity in a patient population. Med Care 1988;26:724-35.
47. Bergner M, Bobbitt RA, Carter WB, Gilson BS. The Sickness impact Profile: Development and final revision of a health status measure. Med Care 1981;19:787-805.
48. Harrell FE, Lee KL, Matcher DB, Reichert TA. Regression models for prognostic prediction: Advantages, problems, and suggested solutions. Cancer Treat Rep 1985;69:1071-77.
49. Sox HC, Blatt MA, Higgins MC, Marton HI. Medical decision making. Boston: Butterworths Publishing, 1988.
50. Feinstein AR, Rubinstein JF, Ramshaw WA. Estimating prognosis with the aid of a conversational-mode computer program. Ann Intern Med 1972;76:911-21.